The goal of this Life Grand Challenge, sponsored by Life Technologies, is to improve the capabilities of the Next Generation Sequencing technology to reach the ability to monitor the genome and transcriptome derived from a single human cancer cell.
This is a Reduction-to-Practice Challenge that requires a written proposal and experimental proof-of-concept data. Please read carefully the Challenge Agreement(entitled Life Technologies Grand Challenge Terms and Conditions).
This Challenge is being run by
The goal of this Life Technologies Grand Challenge is to design a comprehensive molecular biology tool box allowing surveillance of the genome and transcriptome derived from a single human cancer cell.
The Winning Solution will be determined by a panel of external judges who will perform a detailed evaluation of all experimental data, including a review of the validation data to ascertain that the final submission meets all criteria and requirements set forth in the Detailed Description and Solution Requirements for this Challenge.
The last date on which validation data can be submitted is November 30, 2012.
In order to be able to win this Grand Challenge, the Solvers will have to adhere to the following protocol:
Internal and external judges will review the submission package and determine whether all the requirements set forth in the Detailed Description and Solution Requirements for this Challenge were met.
The Solvers will also have to agree, upon entry submission, to grant Life Technologies a non-exclusive, fully paid license to any and all intellectual property associated with the submission. The Winning Solver will assign exclusive ownership of all intellectual property to Life Technologies per the Challenge Agreement and as a condition of collecting the full award.
What is an RTP Challenge?
An InnoCentive RTP (Reduction to Practice) Challenge is a prototype that proves an idea, and is similar to an InnoCentive Theoretical Challenge in its high level of detail. However, an RTP requires the Solver to submit a validated solution, either in the form of original data or a physical sample. Also the Seeker is allowed to test the proposed solution. For details about treatment of IP rights, please see the Challenge-Specific Agreement.